You searched for "macular"
Acetazolamide and CMO
1 August 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The authors set out to analyse the effect of acetazolamide therapy on inflammatory cystoid macular oedema (CMO) as defined by change in central macular subfield thickness (CST), as well as its effect on visual acuity. A retrospective chart review was...
Developments in Ophthalmology: Ophthalmic Radiation Therapy Techniques and Applications
1 February 2015
| Sofia Rokerya
|
EYE - Paediatrics, EYE - Strabismus, EYE - General, EYE - Neuro-ophthalmology
Radiation was discovered by Wilhelm Roentgen in 1895, and since then has been used to treat a variety of cancers. Its therapeutic properties have been widely used for ocular and periocular tumours and inflammatory disease, but the present era is...
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of CMO after phacoemulsification
This is a prospective randomised clinical trial study including patients older than 40 years with age related cataract and normal ophthalmic examination. The patients are randomised into three different groups and the objective of the study is to compare the...
Retinal microvasculature in amblyopic eyes
This study evaluated and compared measurements of macular vessel density and foveal avascular zone using optical coherence tomography (OCT) angiography in amblyopia eyes and age-matched controls to determine whether results are in agreement with previous studies. This was a cross...
Wet AMD outcomes post cataract surgery
3 June 2021
| Kareem Waleed Alsaffarini
|
EYE - Cataract, EYE - Refractive
|
age-related cataract, antivascular endothelial growth factor, cataract surgery, wet age-related macular degeneration
The authors present the findings of a retrospective study looking at the progression of wet age-related macular degeneration (AMD) in patients who underwent cataract surgery. They recruited a series of 111 patients of which 38 were men and 73 were...
Laser pointer maculopathy
The objective of this study was to describe the potential clinical presentations of retinal pathology resulting from exposure to laser pointers. The study included eight eyes of seven patients. Mean age was 18.7 years (12-36). Most were accidental self-inflicted while...All eyes on Twiggy as she fronts new campaign warning us: don’t lose focus of your eye health
13 October 2022
Dame Twiggy Lawson fronts a new public awareness campaign focused on eye health, as cases of macular disease increase with our ageing population.
Specialist high-street eye clinics for managing patients with retinal disorders can enhance care standards
The author examines the successful introduction of community-based retinal clinic services by Manchester University NHS Foundation Trust. Dr Sajjad Mahmood, Consultant Ophthalmologist, MREH, shares experience of establishing community-based medical retina clinic services. Sight loss from age-related macular degeneration (AMD), cataract,...What’s new in wet AMD papers?
1 December 2016
| Rod McNeil
|
EYE - Vitreo-Retinal
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
The management of retinal vein occlusions: a summary
1 February 2015
| Amy-lee Shirodkar
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...
A tale of two membranes
1 February 2016
| Jan Huelle
|
EYE - Vitreo-Retinal
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...
